Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2021-10-11 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2021.
Regulatory Filings
2021-10-11 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from Unichem Laboratories Limited addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons. It references the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and specifies the trading window closure period around the announcement of financial results for the quarter and half year ended September 30, 2021. The document is short (1519 characters) and serves as a compliance announcement related to insider trading regulations rather than containing any financial data or report. It does not contain financial statements, management discussion, or any detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for compliance notices and miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-30 English
Pursuant to the Company''s Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition ....
Regulatory Filings Classification · 95% confidence The document is a notice from Unichem Laboratories Limited addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons. It references the upcoming financial results for the quarter and half year ended September 30, 2021, but does not contain any financial data or results itself. The document is short (1519 characters) and serves as a compliance announcement related to insider trading regulations. It is not a financial report, earnings release, or any detailed report but rather a regulatory filing informing about trading restrictions around the financial results announcement. Therefore, it fits best under Regulatory Filings (RNS).
2021-09-30 English
Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg.
Regulatory Filings Classification · 95% confidence The document is a press release dated August 12, 2021, from Unichem Laboratories Limited announcing the receipt of ANDA approval from the USFDA for a pharmaceutical product. It is addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a corporate announcement about a regulatory approval and does not contain financial statements, management discussion, or detailed financial data. The document length is 3593 characters, which is relatively short and typical for a regulatory announcement. There is no indication that this is a full financial report, earnings release, or management report. It is not a report publication announcement since it contains the full announcement text. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-12 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated August 12, 2021, announcing the receipt of ANDA approval from the USFDA for a pharmaceutical product by Unichem Laboratories Limited. It is addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a corporate announcement about regulatory approval and does not contain financial statements, management discussion, or detailed financial data. The document length is 3593 characters, which is relatively short and typical for a press release or regulatory announcement. There is no indication that this is a full financial report, earnings release, or management report. It is not a report publication announcement since it contains the full announcement text. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2021-08-12 English
Pursuant to Regulation 47 of the Listing Regulations, please find attached copies of the Financial Results for the quarter ended June 30, 2021 published in newspapers on August 2, 2021.
Report Publication Announcement Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the publication of financial results for the quarter ended June 30, 2021. It mentions Regulation 47 of the Listing Regulations and states that copies of the financial results were published in newspapers on August 2, 2021. The document is a notification or announcement about the publication of the financial results rather than the financial results report itself. The length is 9154 characters, which is relatively short and consistent with an announcement rather than a full financial report. There is no detailed financial data or analysis present in the text. Therefore, this document fits the category of Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, often stating that the report is attached or available elsewhere.
2021-08-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.